Baxter International Inc.
BAXMedical Instruments & Supplies
$23.00−2.13%As of Oct 30vs prior close
- Market cap
- $11.9B
- P/E (TTM)
- –
- P/E (FY1)
- 11.2×
- From 52W high
- −18.84%
- EPS (LTM)
- -$1.43
- Revenue (LTM)
- $11.6B
- Net margin
- -6.23%
- Dividend yield
- 0.17%
Nomior Score
48
Steady ProfileBottom 46% of the scored universe
Growth24
Quality33
Value69
Momentum74
Resilience48
Growth
+1.13%revenue a year over 9 fiscal years
FY16 $10.2BLTM $11.6B
Connections
Revenue to profitQ3 FY26
10% of revenue became net profit, up 12 pts on a year.
Latest resultsthird-quarter 2026
- Net income
- $298 million
- Diluted EPS
- $0.57
Baxter reported higher sales in the quarter, with growth across all segments and divisions on both reported and organic bases. Adjusted profit declined year over year because of a higher effective tax rate, while GAAP results were supported by a gain on debt extinguishment. The company raised its full-year outlook for both sales growth and adjusted earnings per share.
Who owns it
5funds, 7 tracked portfolios